feasibility study, and making due diligence of the real estate, including the assessment of various risks that may occur from the investment in such real estate together with arranging guidelines to manage the
support remote working and learning during COVID-19 in the prior years. As the COVID-19 situation improved in 2022, the study and work condition are beginning to return to normal, the demand for these
this year, the study and work conditions are beginning to return to normal. When compared to 2022, the Company’s sales revenue for the 3-month period of Q3/2023 amounted to THB 3,586.39 million
with growth higher than the Bank in-house research forecasted of 8.0%. The number of new car sales for the first 11 months of 2017 totaled 767,345 units, a growth of 12.5% with the growth for the
showed continuous recovery with growth higher than the Bank in- house research forecasted of 8.0%. The number of new car sales for total year 2017 totaled 871,647 units, a growth of 13.4% with the growth
. Investment in raw material extraction plant and world-class research laboratory 100 100 100 - 2018-2019 2. Development of the Company’s new brand 200 200 200 - 2018-2020 บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน
percent Purposes of use of proceeds disclosed in the registration statement for offer for sale of securities and draft prospectus 1. Investment in raw material extraction plant and world-class research
กัทรัพย ์(Soft Dollar) เช่น การไดรั้บบทวิเคราะห์ (research) จากการใชบ้ริการนายหนา้ซ้ือขายหลกัทรัพย ์ การไดรั้บเชิญใหไ้ปร่วมงานสัมมนาโดยไดรั้บบริการท่ีพกัและอาหารฟรีจากบริษทัผูอ้อกหลกัทรัพย ์ อนัเน่ืองมาจาก
COMPANY LIMITED ASIA FIBER PUBLIC COMPANY LIMITED ASIA GREEN ENERGY PUBLIC COMPANY LIMITED ASIA HOTEL PUBLIC COMPANY LIMITED ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY
COMPANY LIMITED ASIA FIBER PUBLIC COMPANY LIMITED ASIA GREEN ENERGY PUBLIC COMPANY LIMITED ASIA HOTEL PUBLIC COMPANY LIMITED ASIA MEDICAL AND AGRICULTURAL LABORATORY AND RESEARCH CENTER PUBLIC COMPANY